← Back to Search

Behavioral Intervention

I-CARE for Suicide Attempt (I-CARE Trial)

N/A

Recruiting

Led By JoAnna K Leyenaar, MD, PhD, MPH

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline/hospital admission (t1), hospital discharge/approximately 72 hours after admission (t2), and 30 days (t3), 3 months (t4), and 6 months (t5) postdischarge

Awards & highlights

I-CARE Trial Summary

This trial will test the I-CARE program in children at a medical hospital waiting for mental health treatment. It aims to see if the program can be used at hospitals, if patients and staff like it

Who is the study for?

This trial is for English-speaking children aged 12-17 who are in a medical hospital due to suicidal thoughts or attempts, waiting for mental health treatment. They must be supervised by a safety attendant and can start the day after they're medically cleared.Check my eligibility

What is being tested?

The I-CARE program, which includes videos and workbook activities aimed at reducing emotional distress and suicide risk among hospitalized youth awaiting psychiatric care, is being tested for its effectiveness and acceptability.See study design

What are the potential side effects?

Since I-CARE involves educational materials rather than medication, traditional side effects aren't expected. However, discussing sensitive topics like suicide may cause temporary discomfort or emotional upset.

I-CARE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline/hospital admission (t1), hospital discharge/approximately 72 hours after admission (t2), and 30 days (t3), 3 months (t4), and 6 months (t5) postdischarge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline/hospital admission (t1), hospital discharge/approximately 72 hours after admission (t2), and 30 days (t3), 3 months (t4), and 6 months (t5) postdischarge

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline/hospital admission (t1), hospital discharge/approximately 72 hours after admission (t2), and 30 days (t3), 3 months (t4), and 6 months (t5) postdischarge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Concise Health Risk Tracking (CHRT)

Change in Depression, Anxiety, and Stress Scale, Youth (DASS-Y)

Change in Harkavy-Asnis Suicide Scale (HASS), Suicide Attempt Module (HASS)

Secondary outcome measures

Change in Cunningham Treatment Engagement Readiness to Change Subscale

Change in Efficacy to Cope with Suicidal Thoughts and Urges Scale

Change in My Thoughts About Therapy (MTT; REACH Framework Expectancy Scale)

+2 more

I-CARE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: I-CAREExperimental Treatment1 Intervention

I-CARE (Improving Care, Accelerating Recovery & Education) is a quality improvement program designed to deliver evidence-based psychosocial skills to adolescents during mental health boarding. The program consists of 7 web-based animated videos and workbook exercises, facilitated by licensed nursing assistants/behavioral health technicians/safety attendants who provide one-on-one safety supervision during boarding. I-CARE will be offered to all eligible adolescents who are boarding and only those who agree to participate in a program evaluation will be involved in the research component.

Group II: Usual CareActive Control1 Intervention

These hospitals currently offer basic safety supervision and medical monitoring for adolescents during mental health boarding. This is the "usual care" condition.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH

2,786 Previous Clinical Trials

2,689,600 Total Patients Enrolled

4 Trials studying Suicide Attempt

28,812 Patients Enrolled for Suicide Attempt

Dartmouth-Hitchcock Medical CenterLead Sponsor

524 Previous Clinical Trials

2,540,680 Total Patients Enrolled

Dartmouth CollegeOTHER

81 Previous Clinical Trials

1,416,131 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals meet the eligibility criteria to participate in this research endeavor?

"For eligibility in this research, individuals must exhibit suicidal ideation and fall within the age bracket of 12 to 17 years. The study is currently seeking approximately 109 eligible participants."

Answered by AI

Are potential participants currently able to apply for this ongoing medical study?

"Affirmative. Details available on clinicaltrials.gov confirm the ongoing recruitment for subjects in this investigation. The trial was originally uploaded on February 29, 2024, with the most recent modification dated March 19, 2024. Enrollment is sought for a total of 109 individuals spread across two designated locations."

Answered by AI

How large is the patient cohort enrolled in this medical study?

"Yes, the details on clinicaltrials.gov highlight that this investigation is actively seeking volunteers. The initial posting of the trial was on February 29th, 2024, with the most recent update made on March 19th, 2024. This study aims to enroll a total of 109 participants across two distinct sites."

Answered by AI

Is the research program open to participants younger than 20 years old?

"This research study is open to participants aged 12 to 16 years."

Answered by AI

What are the desired results that researchers hope to achieve through this investigation?

"The primary focus of this medical trial is to evaluate the alteration in Concise Health Risk Tracking (CHRT) at three time points: 30 days post-discharge, after 3 months, and following 6 months. Secondary objectives encompass assessing alterations in The Children's Hope Scale, which gauges hope levels on a scale from "None of the time" to "All of the time," measuring Efficacy to Cope with Suicidal Thoughts and Urges via a self-report questionnaire rating confidence levels across various coping methods, as well as monitoring Disposition change by noting if patients are discharged home or require continued psychiatric hospitalization based"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Care, Accelerating Recovery and Education

JoAnna K. Leyenaar 2024. "Improving Care, Accelerating Recovery and Education". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06233747.